These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 31433989)
1. Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer. Di Mitri D; Mirenda M; Vasilevska J; Calcinotto A; Delaleu N; Revandkar A; Gil V; Boysen G; Losa M; Mosole S; Pasquini E; D'Antuono R; Masetti M; Zagato E; Chiorino G; Ostano P; Rinaldi A; Gnetti L; Graupera M; Martins Figueiredo Fonseca AR; Pereira Mestre R; Waugh D; Barry S; De Bono J; Alimonti A Cell Rep; 2019 Aug; 28(8):2156-2168.e5. PubMed ID: 31433989 [TBL] [Abstract][Full Text] [Related]
2. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Di Mitri D; Toso A; Chen JJ; Sarti M; Pinton S; Jost TR; D'Antuono R; Montani E; Garcia-Escudero R; Guccini I; Da Silva-Alvarez S; Collado M; Eisenberger M; Zhang Z; Catapano C; Grassi F; Alimonti A Nature; 2014 Nov; 515(7525):134-7. PubMed ID: 25156255 [TBL] [Abstract][Full Text] [Related]
3. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis. Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034 [TBL] [Abstract][Full Text] [Related]
4. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells. Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma. Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387 [TBL] [Abstract][Full Text] [Related]
6. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression. Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984 [TBL] [Abstract][Full Text] [Related]
7. PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy. Armstrong CW; Maxwell PJ; Ong CW; Redmond KM; McCann C; Neisen J; Ward GA; Chessari G; Johnson C; Crawford NT; LaBonte MJ; Prise KM; Robson T; Salto-Tellez M; Longley DB; Waugh DJ Oncotarget; 2016 Feb; 7(7):7885-98. PubMed ID: 26799286 [TBL] [Abstract][Full Text] [Related]
8. The CXCR2/CXCL2 signalling pathway - An alternative therapeutic approach in high-grade glioma. Acker G; Zollfrank J; Jelgersma C; Nieminen-Kelhä M; Kremenetskaia I; Mueller S; Ghori A; Vajkoczy P; Brandenburg S Eur J Cancer; 2020 Feb; 126():106-115. PubMed ID: 31927212 [TBL] [Abstract][Full Text] [Related]
10. Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Li Y; He Y; Butler W; Xu L; Chang Y; Lei K; Zhang H; Zhou Y; Gao AC; Zhang Q; Taylor DG; Cheng D; Farber-Katz S; Karam R; Landrith T; Li B; Wu S; Hsuan V; Yang Q; Hu H; Chen X; Flowers M; McCall SJ; Lee JK; Smith BA; Park JW; Goldstein AS; Witte ON; Wang Q; Rettig MB; Armstrong AJ; Cheng Q; Huang J Sci Transl Med; 2019 Dec; 11(521):. PubMed ID: 31801883 [TBL] [Abstract][Full Text] [Related]
11. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression. Wang G; Lu X; Dey P; Deng P; Wu CC; Jiang S; Fang Z; Zhao K; Konaparthi R; Hua S; Zhang J; Li-Ning-Tapia EM; Kapoor A; Wu CJ; Patel NB; Guo Z; Ramamoorthy V; Tieu TN; Heffernan T; Zhao D; Shang X; Khadka S; Hou P; Hu B; Jin EJ; Yao W; Pan X; Ding Z; Shi Y; Li L; Chang Q; Troncoso P; Logothetis CJ; McArthur MJ; Chin L; Wang YA; DePinho RA Cancer Discov; 2016 Jan; 6(1):80-95. PubMed ID: 26701088 [TBL] [Abstract][Full Text] [Related]
12. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. Alimonti A; Nardella C; Chen Z; Clohessy JG; Carracedo A; Trotman LC; Cheng K; Varmeh S; Kozma SC; Thomas G; Rosivatz E; Woscholski R; Cognetti F; Scher HI; Pandolfi PP J Clin Invest; 2010 Mar; 120(3):681-93. PubMed ID: 20197621 [TBL] [Abstract][Full Text] [Related]
13. Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces Re-education of tumor-associated macrophages. Wang H; Shao Q; Wang J; Zhao L; Wang L; Cheng Z; Yue C; Chen W; Wang H; Zhang Y Cancer Lett; 2022 Mar; 529():112-125. PubMed ID: 34999169 [TBL] [Abstract][Full Text] [Related]
14. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851 [TBL] [Abstract][Full Text] [Related]
15. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal. Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780 [TBL] [Abstract][Full Text] [Related]
16. Parisotto M; Grelet E; El Bizri R; Dai Y; Terzic J; Eckert D; Gargowitsch L; Bornert JM; Metzger D J Exp Med; 2018 Jun; 215(6):1749-1763. PubMed ID: 29743291 [TBL] [Abstract][Full Text] [Related]
17. CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13. Tien JC; Luo J; Chang Y; Zhang Y; Cheng Y; Wang X; Yang J; Mannan R; Mahapatra S; Shah P; Wang XM; Todd AJ; Eyunni S; Cheng C; Rebernick RJ; Xiao L; Bao Y; Neiswender J; Brough R; Pettitt SJ; Cao X; Miner SJ; Zhou L; Wu YM; Labanca E; Wang Y; Parolia A; Cieslik M; Robinson DR; Wang Z; Feng FY; Chou J; Lord CJ; Ding K; Chinnaiyan AM Cell Rep Med; 2024 Oct; 5(10):101758. PubMed ID: 39368479 [TBL] [Abstract][Full Text] [Related]
18. Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition. González-Billalabeitia E; Seitzer N; Song SJ; Song MS; Patnaik A; Liu XS; Epping MT; Papa A; Hobbs RM; Chen M; Lunardi A; Ng C; Webster KA; Signoretti S; Loda M; Asara JM; Nardella C; Clohessy JG; Cantley LC; Pandolfi PP Cancer Discov; 2014 Aug; 4(8):896-904. PubMed ID: 24866151 [TBL] [Abstract][Full Text] [Related]
19. CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Gαi-2 and Gαq/11. Chen MC; Baskaran R; Lee NH; Hsu HH; Ho TJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY J Cell Physiol; 2019 Jul; 234(7):11822-11834. PubMed ID: 30552676 [TBL] [Abstract][Full Text] [Related]
20. BMAL1 plays a crucial role in immune homeostasis during sepsis-induced acute lung injury. Zeng T; Liang L; Deng W; Xie M; Zhao M; Wang S; Liu J; Yang M Biochem Pharmacol; 2024 Aug; 226():116379. PubMed ID: 38908531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]